Healthcare
LifeTech Scientific Corporation(LFTSF)
Live Price
Offline$0.2335
+0.00% today
1Y Change
+0.00%
Window
Jun 25, 2025 โ Jun 16, 2026
- Market Cap
- $8.28B
- Revenue Growth
- +2.9%
- EPS Growth
- -13.6%
- Dividend Yield
- 0.0%
Coverage: 252 bars ยท Jun 25, 2025 โ Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
LifeTech Scientific Corporation (LFTSF) is a Healthcare stock with a market cap of $8.28B and listed on OTC. The stock last traded around $0.23 and up 0.0% across the available one-year price window (Jun 25, 2025 โ Jun 16, 2026). Baseline metrics include revenue growth of +2.9%, EPS growth of -13.6%, a dividend yield of 0.0%. What stands out right now is revenue +2.9%, EPS -13.6%, free cash flow -69.3% with operating margin 15.9% and ROIC 3.6%. Valuation already assumes a fairly strong business story at P/E 56.5 and price/sales 6.1. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines LFTSF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+2.9% vs +7.6% peer median
Operating Margin
Below sector median
+15.9% vs +19.4% peer median
P/E
Above sector median
56.5 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2025 was reported on Mar 28, 2025, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +2.9% and EPS is at -13.6%, with operating margin around 15.9%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2025 Mar 28, 2025 | โ | +0.0% | +0.0% | +0.0% |
2024 Aug 30, 2024 | โ | +0.0% | +0.0% | +0.0% |
2024 Mar 28, 2024 | โ | +0.0% | +0.0% | +0.0% |
Benchmark Edge
LFTSF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
LFTSF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
LFTSF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for LFTSF and SPY.
Company Overview
LifeTech Scientific Corporation
Other OTC
LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The company operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. Its products include LAmbre left atrial appendage closure systems, as well as CeraFlex, Cera, Heart, and Konara-MF VSD occluders; Ankura thoracic aortic aneurysm and abdominal aortic aneurysm stent graft systems; delivery systems, such as Fustar steerable and SteerEase introducers; Aegisy vena cava filters; Cera vascular plug systems; AcuMark sizing balloons; LawMax dilators; and SeQure snare systems, as well as pacemakers. The company is also involved in the biomedical research and development; manufacturing and trading of materials for hemp; staff training and internal personnel management business; information consulting for investors; and manufacturing and trading of medical devices, as well as technical, consulting, and technology services. It has operations in Mainland China, India, rest of Asia, Europe, South America, Africa, and internationally. LifeTech Scientific Corporation was founded in 1999 and is headquartered in Shenzhen, the People's Republic of China.
- Leadership
- Yuehui Xie
- IPO Date
- Jun 28, 2021
- Employees
- 1.4k
- Street Address
- LifeTech Scientific Building
- Mailing
- Shenzhen, 518063
- Region
- Shenzhen, CN
- Reporting Currency
- USD
- Investor Line
- 86 75 5860 26250
- Last Updated
- May 1, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 56.5
- EV/EBITDA
- 27.1
- Price/Sales
- 6.1
- Price/Book
- 2.4
Growth
- Revenue
- +2.9%
- EPS
- -13.6%
- Free Cash Flow
- -69.3%
Profitability
- Gross Margin
- 74.4%
- Operating Margin
- 15.9%
- Net Margin
- 10.8%
- ROE
- 4.0%
- ROIC
- 3.6%
Balance Sheet
- Debt/Equity
- 0.00
- Current Ratio
- 1.57
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.